Artificial Intelligence in Diabetes Management Market 2025: Projected to hit USD 2.56 B by 2029 at 33.7% CAGR. Access in-depth analysis on trends, market dynamics, and competitive landscape for data-driven decisions.
The artificial intelligence in diabetes management market size has grown exponentially in recent years, progressing from $0.62 billion in 2024 to $0.8 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. This substantial growth in the historic period can be mainly attributed to an increase in data accumulation, a rising number of diabetes cases, intensifying healthcare cost pressures, and early AI applications. In the forecasted period, the artificial intelligence in diabetes management market size is expected to experience rapid growth, reaching $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 33.7%. This growth can be largely credited to AI-powered decision support systems, telemedicine integration, utilization of genomic data, and regulatory support. Major trends during the forecast period include advancements in wearable technology, personalized treatment plans, advancements in continuous glucose monitoring, AI-powered risk prediction, and support for behavioral modification.
Get Your Free Sample of The Global Artificial Intelligence in Diabetes Management Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp
What Are The Key Drivers Propelling the Artificial Intelligence in Diabetes Management Market?
The escalating prevalence of diabetes is expected to propel the artificial intelligence in the diabetes management market forward. Artificial intelligence plays a pivotal role in managing diabetes, providing information about high or low blood sugar levels and capturing data that has not been used previously. The rising prevalence of diabetes is a significant driver in the growth of the artificial intelligence in the diabetes management market.
What Are the Most Prominent Segments Within the Global Artificial Intelligence in The Diabetes Management Market?
1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report
Which Key Companies Are Operating in The Artificial Intelligence in Diabetes Management Market?
Major companies in the artificial intelligence in diabetes management market include Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
What Are The Emerging Trends in The Artificial Intelligence in Diabetes Management Market?
Technological advancements are an emerging trend gaining popularity in the artificial intelligence in diabetes management market. Major companies operating in the artificial intelligence in diabetes management market are focusing on innovating new and advanced technological solutions to sustain their position in the market.
Which Region Holds The Largest Share in The Artificial Intelligence in Diabetes Management Market?
North America was the largest region in the artificial intelligence in diabetes management market in 2024. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Artificial Intelligence in Diabetes Management Market Report 2025 Offer?
Artificial intelligence in diabetes management refers to the use of AI technologies and algorithms to identify patterns in behaviors that lead to high or low blood sugar levels in diabetes patients. Artificial intelligence in diabetes management improves various aspects of diabetes care, including decision support, prediction, lifestyle guidance, and treatment management. The Artificial Intelligence in Diabetes Management Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12593
About The Business Research Company
Learn More About the Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments
Post a Comment